BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26421273)

  • 21. RNA-Seq-based analysis of changes in Borrelia burgdorferi gene expression linked to pathogenicity.
    Wu Q; Guan G; Liu Z; Li Y; Luo J; Yin H
    Parasit Vectors; 2015 Mar; 8():155. PubMed ID: 25886272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis.
    Steere AC; Angelis SM
    Arthritis Rheum; 2006 Oct; 54(10):3079-86. PubMed ID: 17009226
    [No Abstract]   [Full Text] [Related]  

  • 23. [Borreliosis. Questionable diagnoses, questionable therapies].
    MMW Fortschr Med; 2009 Aug; 151(34-35):20-1. PubMed ID: 19771783
    [No Abstract]   [Full Text] [Related]  

  • 24. The Clinical Relevance of Studies on Borrelia burgdorferi Persisters.
    Baker PJ; Wormser GP
    Am J Med; 2017 Sep; 130(9):1009-1010. PubMed ID: 28502813
    [No Abstract]   [Full Text] [Related]  

  • 25. An appraisal of "chronic Lyme disease".
    Maloney EL
    N Engl J Med; 2008 Jan; 358(4):428-9; author reply 430-1. PubMed ID: 18219748
    [No Abstract]   [Full Text] [Related]  

  • 26. Stage-specific global alterations in the transcriptomes of Lyme disease spirochetes during tick feeding and following mammalian host adaptation.
    Iyer R; Caimano MJ; Luthra A; Axline D; Corona A; Iacobas DA; Radolf JD; Schwartz I
    Mol Microbiol; 2015 Feb; 95(3):509-38. PubMed ID: 25425211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypothetical Protein BB0569 Is Essential for Chemotaxis of the Lyme Disease Spirochete Borrelia burgdorferi.
    Zhang K; Liu J; Charon NW; Li C
    J Bacteriol; 2015 Dec; 198(4):664-72. PubMed ID: 26644432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistence of borrelial DNA in the joints of Borrelia burgdorferi-infected mice after ceftriaxone treatment.
    Yrjänäinen H; Hytönen J; Hartiala P; Oksi J; Viljanen MK
    APMIS; 2010 Sep; 118(9):665-73. PubMed ID: 20718718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Borrelia burgdorferi-associated primary cutaneous marginal-zone B-cell lymphoma: a case report.
    Monari P; Farisoglio C; Calzavara Pinton PG
    Dermatology; 2007; 215(3):229-32. PubMed ID: 17823520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical analysis of treatment trials of rhesus macaques infected with Borrelia burgdorferi reveals important flaws in experimental design.
    Wormser GP; Baker PJ; O'Connell S; Pachner AR; Schwartz I; Shapiro ED
    Vector Borne Zoonotic Dis; 2012 Jul; 12(7):535-8. PubMed ID: 22620495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Genetically strange Borrelia and conservation of genes associated with motility in Lyme disease Borrelia].
    Yanagihara Y; Masuzawa T
    Nihon Saikingaku Zasshi; 1996 Oct; 51(4):1015-24. PubMed ID: 8994346
    [No Abstract]   [Full Text] [Related]  

  • 32. Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with lyme disease.
    Stricker RB
    Clin Infect Dis; 2007 Jul; 45(2):149-57. PubMed ID: 17578772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Borrelia burgdorferi outer surface protein (osp) B expression independent of ospA.
    Liang FT; Caimano MJ; Radolf JD; Fikrig E
    Microb Pathog; 2004 Jul; 37(1):35-40. PubMed ID: 15194158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of rpsL as a Counterselectable Marker in Borrelia burgdorferi.
    Drecktrah D; Douglas JM; Samuels DS
    Appl Environ Microbiol; 2010 Feb; 76(3):985-7. PubMed ID: 19966024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-tumor necrosis factor-alpha treatment activates Borrelia burgdorferi spirochetes 4 weeks after ceftriaxone treatment in C3H/He mice.
    Yrjänäinen H; Hytönen J; Song XY; Oksi J; Hartiala K; Viljanen MK
    J Infect Dis; 2007 May; 195(10):1489-96. PubMed ID: 17436229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment.
    Bockenstedt LK; Mao J; Hodzic E; Barthold SW; Fish D
    J Infect Dis; 2002 Nov; 186(10):1430-7. PubMed ID: 12404158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lyme disease: recent advances and perspectives.
    Petnicki-Ocwieja T; Brissette CA
    Front Cell Infect Microbiol; 2015; 5():27. PubMed ID: 25883907
    [No Abstract]   [Full Text] [Related]  

  • 38. Identification of new compounds with high activity against stationary phase Borrelia burgdorferi from the NCI compound collection.
    Feng J; Shi W; Zhang S; Zhang Y
    Emerg Microbes Infect; 2015 Jun; 4(6):e31. PubMed ID: 26954881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Borrelia burgdorferi--a unique bacterium].
    Brorson Ø
    Tidsskr Nor Laegeforen; 2009 Oct; 129(20):2114-7. PubMed ID: 19855450
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of effectiveness of cefovecin, doxycycline, and amoxicillin for the treatment of experimentally induced early Lyme borreliosis in dogs.
    Wagner B; Johnson J; Garcia-Tapia D; Honsberger N; King V; Strietzel C; Hardham JM; Heinz TJ; Marconi RT; Meeus PF
    BMC Vet Res; 2015 Jul; 11():163. PubMed ID: 26205247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.